1.
Gypenosides improved inflammatory status, insulin resistance and hepatic steatosis in obese C57BL/6J mice : Gypenosides improved inflammatory status in obese mice. JFB [Internet]. 2023 Mar. 30 [cited 2026 Oct. 24];21. Available from: http://www.isnff-jfb.com/index.php/JFB/article/view/316